Literature DB >> 28874326

Ambicor Two-Piece Inflatable Penile Prosthesis: Background and Contemporary Outcomes.

Oliver S Ko1, Nelson E Bennett2.   

Abstract

INTRODUCTION: The two-piece inflatable penile prosthesis (IPP; Ambicor) might be a preferred option for men with erectile dysfunction (ED) who have significant retroperitoneal scarring, limited manual dexterity, or other issues. There are reported differences in outcomes and patient and partner satisfaction between three-piece and two-piece IPPs. AIM: To report contemporary outcomes, patient and partner satisfaction, and mechanical durability data of the two-piece compared with the three-piece IPP.
METHODS: A PubMed search was performed related to two-piece penile prostheses. Emphasis was placed on perioperative outcomes and patient and/or partner satisfaction scores. Non-English-language articles were excluded. MAIN OUTCOME MEASURES: Use of the Ambicor two-piece penile prosthesis was assessed by outlining the contemporary literature. The etiology of ED in this population, mechanical attributes, penile morphologic changes, satisfaction, and its use in special populations were reviewed.
RESULTS: The most common etiology of ED for placement of the device remains a vasculogenic cause (range = 11-62%). Overall complication rates were 2.1% to 11.2% for the general population. Mechanical failure was seen in 0.7% to 6.1%. Infection rates were 0.7% to 4.8%. Spontaneous deflation was seen in approximately 25%. Higher complication rates were found in transgender patients after neophallus creation and the two-piece IPP could offer better durability compared with the three-piece IPP. Longer operative times, greater use of advanced dilation techniques, and greater length loss also have been reported. Overall satisfaction rates are higher than 85%.
CONCLUSION: The predominant etiology of ED for two-piece penile prosthesis placement is vasculogenic. There is a trend toward IPP insertion in patients after radical prostatectomy or who have spinal cord injury. The two-piece device has similar complication rates and high patient satisfaction scores compared with three-piece IPPs. Further larger prospective studies are needed to validate our findings, resolve discrepancies in published outcomes, and contribute to the sparse data on this subject. Ko OS, Bennett NE. Ambicor Two-Piece Inflatable Penile Prosthesis: Background and Contemporary Outcomes. Sex Med Rev 2018;6:319-327.
Copyright © 2017 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ambicor; American Medical Systems; Erectile Dysfunction; Penile Prosthesis; Post Prostatectomy Erectile Dysfunction; Sexual Dysfunction; Two-Piece Penile Prosthesis

Mesh:

Year:  2017        PMID: 28874326     DOI: 10.1016/j.sxmr.2017.07.010

Source DB:  PubMed          Journal:  Sex Med Rev        ISSN: 2050-0521


  6 in total

Review 1.  Penile Implant Considerations in the Bladder Cancer Survivor.

Authors:  Jeffrey C Loh-Doyle
Journal:  Curr Urol Rep       Date:  2019-01-28       Impact factor: 3.092

2.  Trends in penile prosthesis implantation and analysis of predictive factors for removal.

Authors:  Kai Li; Eileen R Brandes; Steven L Chang; Jeffrey J Leow; Benjamin I Chung; Ye Wang; Jairam R Eswara
Journal:  World J Urol       Date:  2018-09-24       Impact factor: 4.226

Review 3.  Fundamentals of prosthetic urology.

Authors:  Kole P Akula; Omer A Raheem
Journal:  Asian J Androl       Date:  2020 Jan-Feb       Impact factor: 3.285

Review 4.  Modern treatment strategies for penile prosthetics in Peyronie's disease: a contemporary clinical review.

Authors:  Matthew J Ziegelmann; M Ryan Farrell; Laurence A Levine
Journal:  Asian J Androl       Date:  2020 Jan-Feb       Impact factor: 3.285

5.  Feasibility of an External Erectile Prosthesis for Transgender Men Who have Undergone Phalloplasty.

Authors:  Elizabeth R Boskey; Divya Jolly; Geetika Mehra; Oren Ganor
Journal:  Sex Med       Date:  2022-08-13       Impact factor: 2.523

Review 6.  Narrative review of penile prosthetic implant technology and surgical results, including transgender patients.

Authors:  Michael Polchert; Brian Dick; Omer Raheem
Journal:  Transl Androl Urol       Date:  2021-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.